$1.450
+0.096 (+6.62%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Cellyan Biotechnology Co Ltd (HKPD) Moving Averages Convergence Divergence (MACD) indicator is -0.30, suggesting HKPD is Strong sell.
Cellyan Biotechnology Co Ltd (HKPD) 20-Day simple moving average is 2.02, while Cellyan Biotechnology Co Ltd (HKPD) share price is $—, making it Sell.
Cellyan Biotechnology Co Ltd (HKPD) 60-Day simple moving average is 3.36, while Cellyan Biotechnology Co Ltd (HKPD) share price is $—, making it Sell.
Technical Analysis for HKPD
AI Technical HKPDAs of 2026-11-07, the technical board for Cellyan Biotechnology Co Ltd (HKPD) reads strong sell: 2 indicators are flashing buy, 9 are indicating sell, and 2 are neutral. Price at $1.45 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 29.666, MACD stands at -0.3 (Sell), Stochastic %K stands at 13.364 (Buy), Stochastic %D stands at 22.489 and CCI stands at -220.714 (Buy).
HKPD trades below the 60-day SMA (3.36) and below the 200-day SMA (8.99). Immediate resistance sits at Classic R1 2.44, then R2 2.97. Support sits at Classic S1 1.36, then S2 0.81.
Cellyan Biotechnology Co Ltd (HKPD) Support & Resistance Level
Cellyan Biotechnology Co Ltd (HKPD) Technical Indicators
2026-11-07
| Name | Value |
|---|---|
| RSI_14 | 29.666 |
| STOCHk_14_3_3 | 13.364 |
| STOCHd_14_3_3 | 22.489 |
| CCI_20 | -220.714 |
| AO_5_34 | -0.316 |
| MOM_10 | -0.550 |
| MACD_12_26_9 | -0.300 |
Cellyan Biotechnology Co Ltd (HKPD) Relative Strength Index (RSI_14) is 29.666, creating a Buy signal.
Cellyan Biotechnology Co Ltd (HKPD) Stochastic %K is 13.364, creating a Buy signal.
Cellyan Biotechnology Co Ltd (HKPD) Stochastic %D is 22.489, creating a Neutral signal.
Cellyan Biotechnology Co Ltd (HKPD) CCI_20 is -220.714, creating a Buy signal.
Cellyan Biotechnology Co Ltd (HKPD) Awesome Oscillator (AO) is -0.316, creating a Sell signal.
Cellyan Biotechnology Co Ltd (HKPD) Momentum (MOM) is -0.550, creating a Sell signal.
Cellyan Biotechnology Co Ltd (HKPD) Moving Average Convergence Divergence (MACD) is -0.300, creating a Sell signal.
Cellyan Biotechnology Co Ltd (HKPD) Moving Average
2026-11-07
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 1.686 | Sell |
| MA_10 | 1.911 | Sell |
| MA_20 | 2.022 | Sell |
| MA_60 | 3.356 | Sell |
| MA_200 | 8.993 | Sell |
| MA_250 | 10.704 | Sell |
Cellyan Biotechnology Co Ltd (HKPD) 5-Day simple moving average is 1.686, while Cellyan Biotechnology Co Ltd (HKPD) share price is $, making it a Sell.
Cellyan Biotechnology Co Ltd (HKPD) 10-Day simple moving average is 1.911, while Cellyan Biotechnology Co Ltd (HKPD) share price is $, making it a Sell.
Cellyan Biotechnology Co Ltd (HKPD) 20-Day simple moving average is 2.022, while Cellyan Biotechnology Co Ltd (HKPD) share price is $, making it a Sell.
Cellyan Biotechnology Co Ltd (HKPD) 60-Day simple moving average is 3.356, while Cellyan Biotechnology Co Ltd (HKPD) share price is $, making it a Sell.
Cellyan Biotechnology Co Ltd (HKPD) 200-Day simple moving average is 8.993, while Cellyan Biotechnology Co Ltd (HKPD) share price is $, making it a Sell.
Cellyan Biotechnology Co Ltd (HKPD) 250-Day simple moving average is 10.704, while Cellyan Biotechnology Co Ltd (HKPD) share price is $, making it a Sell.
Related articles
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.